NCT03212144

Brief Summary

This study will enroll and randomly assign 30 sedentary, healthy overweight men and women to two groups. Participants will either start by consuming peanuts for 4 weeks, and then go on to exercise at high intensity intervals (HIIT) for 4 weeks, or the reverse order. The study will test and compare the effect of peanuts and exercise on inflammation and heart rate variability as indicators of heart health. Specifically, the study will measure inflammation in the blood because there is evidence that higher inflammation is found in heart disease patients. There is also evidence that inflammation is related to death as a result of heart disease in healthy individuals. Finally, there are ongoing trials targeting these markers to improve heart health. The study hypothesizes that peanuts and exercise will reduce inflammation. It is also expected to find less inflammation because exercise and peanut consumption activate a part of the nervous system that has been shown to cause a similar effect. Additionally, previous studies show that inflammation involves the mitochondria in the cell, the part of the cell that produces energy. For this reason, it is expected that exercise and peanuts will cause changes in the mitochondria. The study will test and compare mitochondrial activity in response to peanut consumption and exercise.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 11, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

August 20, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
3 months until next milestone

Results Posted

Study results publicly available

April 6, 2020

Completed
Last Updated

April 6, 2020

Status Verified

March 1, 2020

Enrollment Period

1.4 years

First QC Date

June 8, 2017

Results QC Date

December 18, 2019

Last Update Submit

March 24, 2020

Conditions

Keywords

nutsexercisevagal activitypeanutsheart rate variability

Outcome Measures

Primary Outcomes (1)

  • Plasma Levels of Pro-inflammatory Cytokines (IL-6 and TNF-α)

    cytokines (IL-6 and TNF-α) will be collected from blood samples

    at study entry

Study Arms (2)

High Intensity Interval Training then Peanut Consumption

EXPERIMENTAL

Exercise group: 4 training sessions/week, 24 hour rest-periods between each training day. 3-min low intensity warm-up, and then exercise as rapidly as possible for 20 seconds, aiming to reach 85% of their maximum heart rate established during the submaximal cardiopulmonary exercise testing. Then followed by 40 seconds of low intensity exercise. Peanut group: Regular daily caloric intake estimated using data from 24hr recalls, the Miflin-St. Jeor equation, and stress/activity factors. Participants consume dry roasted, unsalted peanuts equivalent to approximately 10% of daily energy intake twice a day, range from approximately 2.4-3.6 ounces. Daily caloric intake will not differ from participants' typical diet. Participants are asked to bring back the empty, numbered peanut packets by the end of every week and will be given new packets weekly. Additionally, subjects will be informed that they will be randomly assessed weekly for compliance.

Other: High Intensity Interval Training

Peanut Consumption then High Intensity Interval Training

EXPERIMENTAL

Exercise group: 4 training sessions/week, 24 hour rest-periods between each training day. 3-min low intensity warm-up, and then exercise as rapidly as possible for 20 seconds, aiming to reach 85% of their maximum heart rate established during the submaximal cardiopulmonary exercise testing. Then followed by 40 seconds of low intensity exercise. Peanut group: Regular daily caloric intake estimated using data from 24hr recalls, the Miflin-St. Jeor equation, and stress/activity factors. Participants consume dry roasted, unsalted peanuts equivalent to approximately 10% of daily energy intake twice a day, range from approximately 2.4-3.6 ounces. Daily caloric intake will not differ from participants' typical diet. Participants are asked to bring back the empty, numbered peanut packets by the end of every week and will be given new packets weekly. Additionally, subjects will be informed that they will be randomly assessed weekly for compliance.

Other: Peanut Consumption

Interventions

Subjects will exercise according the the high intensity aerobic interval training regiment four times a week for four weeks

Also known as: Aerobic Exercise
High Intensity Interval Training then Peanut Consumption

Subjects will consume peanuts twice a day to replace 20% of their daily caloric intake for four weeks.

Peanut Consumption then High Intensity Interval Training

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Of either sex,
  • age 21-45 years
  • English-speaker
  • Overweight or obese
  • sedentary

You may not qualify if:

  • Cardiovascular disease
  • Uncontrolled high blood pressure (blood pressure ≥ 140/90). Individuals with controlled hypertension (i.e. under medical treatment) and blood pressure lower than 140/90 will not be excluded.
  • Active hepatic disease (not a history of hepatitis) or primary renal disease requiring dialysis, primary untreated endocrine diseases, e.g., Cushing's disease or primary hypothalamic failure or insulin dependent diabetes (Type I or II).
  • HIV infection
  • Pregnant or lactating (participation allowed 3 months after ceasing lactation).
  • Medications that alter inflammation or autonomic nervous system activity.
  • Any history of psychosis or ECT
  • Psychotic disorder (lifetime)
  • Current or recent (past 5 years) Major Depressive Disorder, Bipolar Disorder, or Anxiety disorder
  • Current or recent (within past 12 months) alcohol or substance abuse or dependence. Recent use (past month) of recreational drugs.
  • Probiotic and dietary supplements that affect inflammation or the ANS
  • Physically active
  • Peanut allergy in subject or in family of subject. Subjects who are unsure of their allergy status will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Medical Center

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Motor Activity

Interventions

High-Intensity Interval TrainingExercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Dr. Richard Sloan
Organization
Columbia University

Study Officials

  • Richard p Sloan, PhD

    CUMC/NYSPI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Data collection staff is masked
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

June 8, 2017

First Posted

July 11, 2017

Study Start

August 20, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2019

Last Updated

April 6, 2020

Results First Posted

April 6, 2020

Record last verified: 2020-03

Locations